Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer (BC), and it accounts for approximately 10%–20% of all invasive BCs diagnosed worldwide. The survival rate of TNBC in stages III and IV is very low, and a large number of patients are diagnosed in these stages....

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Md Shahin Alam, Adiba Sultana, Guanghui Wang, Md Nurul Haque Mollah
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Frontiers Media S.A. 2022-12-01
Sraith:Frontiers in Molecular Biosciences
Ábhair:
Rochtain ar líne:https://www.frontiersin.org/articles/10.3389/fmolb.2022.1049741/full

Míreanna comhchosúla